Document is current
Any future updates will be listed below
-
Authors
Cananzi, Mara https://orcid.org/0000-0002-7177-2847
Wohler, Elizabeth
Marzollo, Antonio
Colavito, Davide
You, Jing
Jing, Huie
Bresolin, Silvia
Gaio, Paola
Martin, Renan
Mescoli, Claudia
Bade, Sangeeta
Posey, Jennifer E.
Dalle Carbonare, Maurizio
Tung, Wesley
Jhangiani, Shalini N.
Bosa, Luca
Zhang, Yu
Filho, Joselito Sobreira
Gabelli, Maria
Kellermayer, Richard
Kader, Howard A.
Oliva-Hemker, Maria
Perilongo, Giorgio
Lupski, James R.
Biffi, Alessandra
Valle, David
Leon, Alberta
de Macena Sobreira, Nara Lygia
Su, Helen C.
Guerrerio, Anthony L.
- License Information
-
More Information
Article History
Received: 27 March 2021
Accepted: 7 June 2021
First Online: 29 June 2021
Declarations
:
: Baylor College of Medicine and Miraca Holdings Inc. have formed a joint venture with shared ownership and governance of Baylor Genetics (BG), formerly the Baylor Miraca Genetics Laboratories, which performs CMA and clinical ES. J.R.L. serves on the Scientific Advisory Board of the BG. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. A.L. has a share in ownership of Research & Innovation (R&I Genetics) Srl. The other authors declare that they have no conflict of interest.
